Celonic’s small-scale asset offers opportunities for Clinical Supply for IND, Phase II resupply and Phase III PPQ and launch supply, with a range of Bioreactor scales ranging from 50L to 1000L. The asset is fitted to conduct cell culture using a variety of processes, including classical fed-batch, N-1 perfusion (intensified fed-batch) and Full N-Reactor perfusion supporting up to 2 Volume Vessels media per Day (VVD).

The equipment in the Biological Development Center in Basel and the Small Scale asset in Heidleberg, have the same family of Bioreactors and downstream equipment offering ease of technology transfer between development and GMP manufacturing